Personalized Nutrition Principles and Applications 1st Edition ISBN 0367388715, 9780367388713 Full-Feature Download
Personalized Nutrition Principles and Applications 1st Edition ISBN 0367388715, 9780367388713 Full-Feature Download
Edition
Visit the link below to download the full version of this book:
https://medidownload.com/product/personalized-nutrition-principles-and-applicati
ons-1st-edition-2/
Section II
Personalized Nutrition and Stakeholders in Society........................................149
Section III
The Future of Personalized Nutrition ...............................................................235
Index ......................................................................................................................279
9281_C000.fm Page v Thursday, July 26, 2007 7:30 PM
Foreword
PERSONALIZED NUTRITION: HISTORY
AND PROMISES?
Personalized nutrition is an emerging but controversial new discipline among nutri-
tion scientists. Due to its possible genetic component, it has become an attractive
topic for the media. So far, the “science fiction” stories of a lady doing food shopping,
guided by a PDA containing her genome information are not taken very seriously.
Of course, in the developed world, personalized food choice is taken for granted.
Did you realize that while ordering Italian three-taste gelato, you can choose from
over a million combinations and variations, if you consider tastes, sizes, toppings,
and packaging? The same is true for coffee or take-away pizzas.
In the context of this book, personalized nutrition is related to a differentiated
health effect, with the key questions targeted at the possible scientific basis for this
phenomenon. In order to put this in the right perspective, let us have a look at the
historical development of the diet and health relationship. Until the early twentieth
century, nutritional sciences dealt with hygiene and processing. This was followed
by the incorporation of biochemistry and (molecular) physiology: the vitamins were
described, energy metabolism was understood, etc. During the second half of the
twentieth century, knowledge of cellular and molecular biological processes allowed
for further optimizing of our diet toward a balanced macro- and micronutrient
composition. This contributed to a prolongation of life span and produced a com-
mercial wave of supplements.
Gradually, nutrition scientists indicated the involvement of diet in a large number
of diseases and disorders (e.g., colon cancer, cardiovascular disorders, type 2 diabetes
mellitus, a number of inflammation-related health problems, and many more. During
the 1990s, this development triggered the introduction of functional foods, dietary
components with “added health value.” So far, these functional foods, apart from
the aforementioned supplements (vitamins, cofactors, minerals, and so forth, which
I do not consider to be real functional foods), have resulted in only a limited number
of successful products (cholesterol-lowering stanols, probiotics, a number of specific
fatty acids). Except for the cholesterol-lowering products, where an established
biomarker (the relationship between CVD and HDL/LDL cholesterol) was estab-
lished by the biomedical research community, it was very difficult to obtain scientific
proof of efficacy for most other functional foods. In many cases, the advertisement
and PR efforts by far outreached the scientific efforts accompanying the market
introduction.
Why does nutrition science have such a hard job in providing evidence for health
claims related to a dietary component? In pharmacological and biomedical research,
bioactive compounds are developed to treat a well-characterized disease. In contrast,
nutrition deals with prevention of disease and optimizing health. Here, biomarkers
9281_C000.fm Page vi Thursday, July 26, 2007 7:30 PM
quantifying the health status are essentially missing, and much of the nutrition
research (the large observational and intervention cohorts) rely on disease endpoints
instead of health endpoints. Also in the “gold standard” of diet and health research,
the (cross-over) dietary intervention trial, the quantification of the effect is a major
issue. Usually, the observed effects are small, and great efforts have to be made to
unravel the intervention effect from potential confounding variables. In other words,
the confounding parameters have a larger impact than the intervention effects. The
recent omics-related observations in human intervention studies, using very accurate
biomarkers, confirm that intraindividual variation is much smaller than interindividual
variation. Differences between study subjects may be much larger than differences
affected by the dietary treatment.
The keys for personalized nutrition actually are these “confounders” that make
the life of nutrition scientists so difficult. Age, gender, lifestyle (e.g., exercise),
phenotype (e.g., body mass index), genetic makeup, and epi-genomic imprinting —
all possibly determine our nutritional needs, the way we respond to nutrition, and
thus our “personal diet-and-health relationship.” Infant nutrition clearly differs from
a sports diet. Now, a triad of questions arise:
This book at least attempts to answer these questions. My personal opinion is that
indeed this relationship exists to a much greater extent than assumed until now, and
that nutrition science will need to do a much better job in accurately identifying and
quantifying the subtle differences in health status related to dietary treatment. A
complete merger of nutrition with a number of fundamental scientific disciplines
(molecular biology, biochemistry, bioinformatics, statistics, etc.) will be essential to
reach the goal.
Now, what about this specific and overemphasized part of personalized nutrition,
the impact of genetic differences? Of course, we know the examples of cholesterol
and folate, where genetic predisposition partly determines plasma concentration and
related health effects. In the case of cholesterol, a phenotypic assessment of LDL
and HDL provides a solid phenotypic biomarker, which makes genetic testing (at
least partly) unnecessary. In fact, this phenotypic readout is the gross result of at
least 20 genetic different makeups. The HDL/LDL relationship partly determines
biomedical intervention and the consumer’s food choice. In the case of folate, the
occurrence of a genetic polymorphism in one of the enzymes involved in folate
biotransformation results in a relatively low plasma folate concentration. In extreme
cases, this leads to embryonic deformation (spina bifida) due to impaired DNA
synthesis. Folate is essential for DNA synthesis as it provides the methyl group for
nucleotide synthesis. Folate is cheap, and some countries have turned to folate
supplementation to the general population (e.g., by fortification of bread). In other
words, a genetically based differential dietary advice is overruled by mass treatment.
9281_C000.fm Page vii Thursday, July 26, 2007 7:30 PM
Possible negative consequences in persons efficiently dealing with folate (high folate
levels have been shown to overmethylate DNA and are thus potentially mutagenic
and carcinogenic) were considered nonrelevant. Time will tell whether a personalized
approach would be better.
A number of disorders related to nutrition are packed with genetic variation, but
the effect of nutritional modulation of the phenotypic outcome of these variations
is difficult to assess as yet. Nutrition is the worst-case scenario for this approach in
science as multiple minor genetic differences can occur, possibly modulated by
multiple food bioactives, usually with low receptor affinity, and resulting in multiple
minor changes in gene expression and resulting phenotypic expression.
Eventually, nutrition science may very likely determine a large number of per-
sonalized nutrition and health relationships. However, this is only a small part of
the equation. Food consumption nowadays is only partially driven by health con-
cerns. It is still much more driven by convenience and price. “Food is pleasure”
rightfully is a universally held credo, and science will have a hard job in promoting
healthy diet if this aspect is compromised. Therefore, a personalized diet needs to
be both optimized toward personal health and also for personal convenience, plea-
sure, and affordability. What a challenge!
Preface
The primary role of diet is to provide an individual with optimal levels of nutrients
to meet metabolic requirements, and to give the consumer a feeling of satisfaction
and well being through the pleasure of eating. In addition, particular diets, foods
and food components can provide additional physiological, cognitive and psycho-
logical benefits, and result in biological activities beyond their widely accepted
nutritional effects. Moreover, diet not only helps to achieve and maintain optimal
health and development but can also play an important role in reducing the risk of
specific diseases and disorders.
However, a diet that serves the health of one individual does not necessarily
work for all individuals due to differences in (genetic) predisposition, and environ-
mental and lifestyle factors. Hence, diagnostic tools that reflect both the overall
health status and (genetic) predisposition of a particular person at a given time need
to be developed. The knowledge obtained thereby will facilitate appropriate nutri-
tional advice to individuals according to their immediate and long-term health needs
and, ultimately, we can foresee the time when nutritional products will be tailored
for individual consumers.
The success of the introduction of personalized nutrition in society depends on many
factors. The scientific background for this must be established, the regulatory system
must be in place, ethical issues need to be addressed, services and products with clear
health benefits must be available, and the accompanying communication must be clear.
This textbook has the aim of defining the area of personalized nutrition both
from a biomedical and social science perspective. A selected group of leading
scientists in the field will comprehensively address the molecular, physiological,
epidemiologic, and public health aspects of personalized nutrition, highlighted with
examples from major diseases. Another group of well-known social scientists will
discuss the behavioral, ethical, and consumer perspectives that will influence a
legitimate successful introduction of personalized nutrition.
We expect our book will be useful for the education of students in several
disciplines, for example, nutrition, behavioral and communication science. More-
over, stakeholders involved in personalized nutrition in government, health care, and
business may use the book as a reference guide.
Our book is divided in three sections: (1) Scientific Principles of Personalized
Nutrition, (2) Personalized Nutrition: Consumer and Society, and (3) Future Per-
spectives on Personalized Nutrition.
In the first section, Scientific Principles of Personalized Nutrition, the state of
the art of nutrigenomics technologies, including transcriptomics, proteomics, and
metabolomics, are discussed. Subsequently, the use of genomics technology for a
better understanding of the molecular mechanisms involved in major diet-related
chronic disorders — i.e., chronic inflammation, cardiovascular disease, type 2
diabetes, cancer, and obesity — is addressed.
9281_C000.fm Page x Thursday, July 26, 2007 7:30 PM
Frans J. Kok
Laura Bouwman
Frank Desiere
9281_C000.fm Page xi Thursday, July 26, 2007 7:30 PM
The Editors
Frans J. Kok PhD, is full professor of nutrition and health and head of the Division
of Human Nutrition at Wageningen University, The Netherlands. Moreover, as dean of
Wageningen Graduate Schools, he is responsible for securing the quality of academic
research and training at the university.
Dr. Kok was trained in human nutrition at Wageningen University and in epi-
demiology at Harvard University, Cambridge, Massachusetts. His scientific expertise
covers topics such as energy balance and body composition, diet in disease preven-
tion, and sensory science. He has authored more than 250 original scientific publi-
cations and is a member of the Dutch Health Council and the Academic Board of
Wageningen University. As a faculty member, he has lectured in many courses on
nutrition and health, including the European Nutrition Leadership Program, as well
as in courses in the U.S., Africa, and Asia.
Frank Desiere, PhD, MBA, started his scientific career in the earlier days of biotech-
nology doing research in fermentation technology, microbiology, and biological conver-
sion of xenobiotics, and later joined the Nestlé Research Center in Lausanne, Switzerland,
to work on the ecology and evolution of bacteriophages in milk fermentation. Later, he
initiated a bioinformatics effort at Nestlé and worked on microbial genomics, transcrip-
tomics, and proteomics. Dr. Desiere also initiated Peptideatlas (www.peptideatlas.org)
for the integration of proteomics data with human and other genomes. He was then
responsible for a project involving personalized nutrition at Nestlé that initiated consumer
and patient applications of personalized nutrition concepts in the marketplace. As a result
of this initiative, his interests evolved into the commercial application of scientific con-
cepts in science and nutrition, management of innovation and new business ideas. After
having completed an MBA at IMD Lausanne, Dr. Desiere now works as business
development manager at Roche Diagnostics in Basel, Switzerland. His scientific activities
have resulted in more than 30 peer-reviewed publications and numerous presentations
at international scientific conferences.
9281_C000.fm Page xii Thursday, July 26, 2007 7:30 PM
9281_C000.fm Page xiii Thursday, July 26, 2007 7:30 PM
Contributors
Lydia A. Afman Hannelore Daniel
Nutrition, Metabolism, and Genomics Molecular Nutrition Unit
Division of Human Nutrition Center of Life and Food Sciences
Wageningen University Technical University of Munich
Wageningen Freising-Weihenstephan
The Netherlands Germany
Josh Conway
Cogent Research, LLC J. Bruce German
Cambridge, Massachusetts University of California–Davis
Davis, California
Dolores Corella
Department of Preventive Medicine Michael J. Gibney
University of Valencia UCD Agriculture and Food Science
Genetic and Molecular Epidemiology Centre
Unit University College
Valencia Dublin
Spain Ireland
9281_C000.fm Page xiv Thursday, July 26, 2007 7:30 PM
Danielle R. Reed
Maria A. Koelen Monell Chemical Senses Center
Wageningen University Philadelphia, Pennsylvania
Sub-Department of Communication
Science, Communication Manuela Rist
and Innovation Group Molecular Nutrition Unit
Wageningen Technical University of Munich
The Netherlands Freising-Weihenstephan
Germany
Michiel Korthals Amber Ronteltap
Applied Philosophy Marketing and Consumer Behavior
Social Sciences Group
Wageningen University Wageningen University
Wageningen Wageningen
The Netherlands The Netherlands
9281_C000.fm Page xv Thursday, July 26, 2007 7:30 PM